1. Synthesis and Structure−Activity Relationships of 17β-Substituted 14β-Hydroxysteroid 3-(α-<scp>l</scp>-Rhamnopyranoside)s: Steroids That Bind to the Digitalis Receptor
- Author
-
Frank S. LaBella, John F. Templeton, Yangzhi Ling, and Kirk Marat
- Subjects
Magnetic Resonance Spectroscopy ,Stereochemistry ,medicine.medical_treatment ,Rhamnose ,Chemical synthesis ,Ouabain ,Steroid ,Radioligand Assay ,Structure-Activity Relationship ,chemistry.chemical_compound ,Dogs ,Microsomes ,Drug Discovery ,medicine ,Animals ,Structure–activity relationship ,Myocardium ,Nuclear magnetic resonance spectroscopy ,Ligand (biochemistry) ,chemistry ,Molecular Medicine ,Hydroxysteroid ,Sodium-Potassium-Exchanging ATPase ,Protein Binding ,medicine.drug - Abstract
The preparation of 17beta-substituted 14beta-hydroxysteroid C-3 alpha-L-rhamnopyranosides is described. These derivatives have a 14beta,20-ether, 14beta,20-lactone, or 17beta-CH2CH2OH, -CH2CH2NH2, -CH=CHNO2(E), -CH=CHCOOH(E), -CH(OH)CH2NO2(R), -CH(OMe)CH2NO2(R), -CH2-CH2COOH, or -CH(OH)CH2NH2(R) group. Derivatives were assayed in a radioligand binding assay for [3H]ouabain in membranes from canine heart muscle. The digitalis "receptor" comprises isoenzymes of the ion-pumping enzyme, Na+,K+-ATPase. The 17beta-CH=CHNO2(E), 17beta-CH=CHCOOH(E), and 17beta-CH(OMe)CH2NO2(R) derivatives were the most potent and equivalent to ouabain with low-nanomolar IC50 values. The very potent binding affinity of the disubstituted compound 17beta-CH(OMe)CH2NO2(R) further demonstrates that 17beta-unsaturated substitution is not required for potent binding affinity. This observation may be of value in the separation of cardiotonic and cardiotoxic effects. Tosylation of the 17beta-CH2OH, prepared from the 17beta-CHO by lithium aluminum hydride reduction, yielded the 14beta,17beta-ether. Synthesis of the 17beta-CH2COOH gave the epimeric 14alpha,17alpha- and 14beta,17beta-lactones. Structures have been established by NMR analysis.
- Published
- 1997
- Full Text
- View/download PDF